Singapore

AIA Funds

Investment Objective
This fund seeks to achieve long term capital appreciation through investments on a worldwide basis in equity securities of companies that are engaged in the health care and health science industries. A substantial portion of its portfolio will typically be invested in U.S. companies. Through a bottom-up selection process, the team attempts to determine market leaders with superior research, financial controls and marketing capabilities.

Manager of ILP Fund
AllianceBernstein (Singapore) Ltd.

Name of Underlying Fund
ACMBernstein SICAV International Health Care Portfolio (Luxembourg IHCP)

Manager of Underlying Fund
AllianceBernstein L.P

Benchmark
MSCI World Health Care Index.

Annual Fund Management Fee
1.75% per annum